These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

456 related articles for article (PubMed ID: 25005585)

  • 1. Topical delivery of acyclovir and ketoconazole.
    Jacobs GA; Gerber M; Malan MM; du Preez JL; Fox LT; du Plessis J
    Drug Deliv; 2016; 23(2):631-41. PubMed ID: 25005585
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Formulation and evaluation of selected transmucosal dosage forms containing a double fixed-dose of acyclovir and ketoconazole.
    Viljoen JM; Botes D; Steenekamp JH
    Eur J Pharm Sci; 2018 Jan; 111():503-513. PubMed ID: 29080856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synergetic skin targeting effect of hydroxypropyl-β-cyclodextrin combined with microemulsion for ketoconazole.
    Che J; Wu Z; Shao W; Guo P; Lin Y; Pan W; Zeng W; Zhang G; Wu C; Xu Y
    Eur J Pharm Biopharm; 2015 Jun; 93():136-48. PubMed ID: 25845772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimised transdermal delivery of pravastatin.
    Burger C; Gerber M; du Preez JL; du Plessis J
    Int J Pharm; 2015 Dec; 496(2):518-25. PubMed ID: 26505148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the in vitro skin permeation of antiviral drugs from penciclovir 1% cream and acyclovir 5% cream used to treat herpes simplex virus infection.
    Hasler-Nguyen N; Shelton D; Ponard G; Bader M; Schaffrik M; Mallefet P
    BMC Dermatol; 2009 Apr; 9():3. PubMed ID: 19341466
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Study of tolnaftate release from fatty acids containing ointment and penetration into human skin ex vivo.
    Kezutyte T; Drevinskas T; Maruska A; Rimdeika R; Briedis V
    Acta Pol Pharm; 2011; 68(6):965-73. PubMed ID: 22125963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Essential Fatty Acids as Transdermal Penetration Enhancers.
    van Zyl L; du Preez J; Gerber M; du Plessis J; Viljoen J
    J Pharm Sci; 2016 Jan; 105(1):188-93. PubMed ID: 26852854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nanoemulsion gel-based topical delivery of an antifungal drug: in vitro activity and in vivo evaluation.
    Hussain A; Samad A; Singh SK; Ahsan MN; Haque MW; Faruk A; Ahmed FJ
    Drug Deliv; 2016; 23(2):642-47. PubMed ID: 25013957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preparation and evaluation of niosome gel containing acyclovir for enhanced dermal deposition.
    Jacob S; Nair AB; Al-Dhubiab BE
    J Liposome Res; 2017 Dec; 27(4):283-292. PubMed ID: 27558522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of ciclopirox olamine topical formulations: evaluation of drug release, penetration and cutaneous retention.
    Pinheiro VA; Serikaku D; Baby AR; Velasco MV; Kaneko TM; Consiglieri VO
    Pharm Dev Technol; 2015 Mar; 20(2):197-203. PubMed ID: 24286179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Formulation, Optimization and Evaluation of Organogel for Topical Delivery of Acyclovir.
    Bonde S; Mavani N; Bonde C
    Curr Drug Deliv; 2018; 15(3):397-405. PubMed ID: 29034838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Formulation, Optimization and Evaluation of Novel Ultra-deformable Vesicular Drug Delivery System for an Anti-fungal Drug.
    Nayak D; Tawale RM; Aranjani JM; Tippavajhala VK
    AAPS PharmSciTech; 2020 May; 21(5):140. PubMed ID: 32419032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of performance matrix for generic product equivalence of acyclovir topical creams.
    Krishnaiah YS; Xu X; Rahman Z; Yang Y; Katragadda U; Lionberger R; Peters JR; Uhl K; Khan MA
    Int J Pharm; 2014 Nov; 475(1-2):110-22. PubMed ID: 25089511
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transungual Delivery of Ketoconazole Nanoemulgel for the Effective Management of Onychomycosis.
    Mahtab A; Anwar M; Mallick N; Naz Z; Jain GK; Ahmad FJ
    AAPS PharmSciTech; 2016 Dec; 17(6):1477-1490. PubMed ID: 26857516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Colloidal nanocarriers for the enhanced cutaneous delivery of naftifine: characterization studies and in vitro and in vivo evaluations.
    Erdal MS; Özhan G; Mat MC; Özsoy Y; Güngör S
    Int J Nanomedicine; 2016; 11():1027-37. PubMed ID: 27042058
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantification of uptake and clearance of acyclovir in skin layers.
    Nair AB
    Antivir Ther; 2016; 21(1):17-25. PubMed ID: 26046929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synergistic penetration of ethosomes and lipophilic prodrug on the transdermal delivery of acyclovir.
    Zhou Y; Wei YH; Zhang GQ; Wu XA
    Arch Pharm Res; 2010 Apr; 33(4):567-74. PubMed ID: 20422366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of stratum corneum and dermal microvascular perfusion in penetration and tissue levels of water-soluble drugs investigated by microdialysis.
    Morgan CJ; Renwick AG; Friedmann PS
    Br J Dermatol; 2003 Mar; 148(3):434-43. PubMed ID: 12653734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Choline and amino acid based biocompatible ionic liquid mediated transdermal delivery of the sparingly soluble drug acyclovir.
    Islam MR; Chowdhury MR; Wakabayashi R; Tahara Y; Kamiya N; Moniruzzaman M; Goto M
    Int J Pharm; 2020 May; 582():119335. PubMed ID: 32311469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Topical Delivery of 5-Fluorouracil from Pheroid™ Formulations and the In Vitro Efficacy Against Human Melanoma.
    Chinembiri TN; Gerber M; du Plessis L; du Preez J; du Plessis J
    AAPS PharmSciTech; 2015 Dec; 16(6):1390-9. PubMed ID: 25956486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.